Progress towards measles and rubella elimination in Lesotho, 2011–2025
PLOS One · 2026
DOI: 10.1371/journal.pone.0358555 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Yankuba Singhateh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Vaccine Preventable Disease Program, East and Southern Africa Inter-Country Support Team, World Health Organization, Harare, Zimbabwe. Hauptthemen laut MEDLINE: Measles, Rubella, Disease Eradication. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Lesotho, a lower middle-income country in southern Africa, has historically had relatively high routine immunization coverage over the last three decades. Since 1996, the country has been implementing measles elimination strategies. This manuscript evaluates Lesotho’s performance, from 2011 to 2025, against the World Health Organization’s criteria for measles and rubella elimination.
Methods
We conducted a retrospective review of Lesotho’s immunization and surveillance data during 2011–2025. This included Lesotho’s annual WHO/UNICEF Estimates of National Immunization Coverage (WUENIC) for routine measles-containing vaccine (MCV) doses; performance in the periodic measles rubella vaccination campaigns and case-based surveillance; and the trends of measles and rubella incidences.
Results
During 2011–2025, MCV1 coverage generally remained ≥90% but failed to reach the 95% elimination target. MCV2 coverage reached 80% in 2011 and 2012 before declining in subsequent years. Lesotho has mostly attained the targets for surveillance performance according to the two principal performance indicators – non-measles febrile rash illness rate and the proportion of districts that report a minimum of one suspected case. From 2011 to 2015, measles incidence stayed below one per 1 million population in Lesotho. However rubella incidence ranged between 33.4 in 2012 to 142.3 in 2014, and declined significantly after MR introduction in 2017.
Conclusion
Lesotho has made significant progress in measles and rubella elimination efforts. To sustain the gains made, the country should work to strengthen vaccination in the second year of life, reinforce demand generation during preventive campaigns, address population denominator inaccuracies that hinder accurate coverage tracking, and systematically document measles and rubella virus genotypes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Vaccine Preventable Disease Program, East and Southern Africa Inter-Country Support Team, World Health Organization, Harare, Zimbabwe.
- Epidemiology and Disease Control Unit, Directorate of Public Health Services, Ministry of Health, Banjul, The Gambia.
- National Immunisation Program, Ministry of Health, Maseru, Lesotho.
- World Health Organization Lesotho Country Office, Maseru, Lesotho.
- Independent Consultant, Maseru, Lesotho.
ORCID-Profile: Yankuba Singhateh
Zitieren
APA
Singhateh, Y., Matoko, T. M., Shaabe, M., Maepe, S. A., Abobo, F. D. N., & Wanyoike, S. W. (2026). Progress towards measles and rubella elimination in Lesotho, 2011–2025. PLOS One. https://doi.org/10.1371/journal.pone.0358555
Vancouver
Singhateh Y, Matoko TM, Shaabe M, Maepe SA, Abobo FDN, Wanyoike SW. Progress towards measles and rubella elimination in Lesotho, 2011–2025. PLOS One. 2026. doi:10.1371/journal.pone.0358555
BibTeX
@article{Singhateh2026,
author = {Singhateh, Yankuba and Matoko, Tshepiso Mechele and Shaabe, Mannini and Maepe, Selloane Amelia and Abobo, Francis Dumobong Ngmenasong and Wanyoike, Sarah Waithera},
title = {Progress towards measles and rubella elimination in Lesotho, 2011–2025},
journal = {PLOS One},
year = {2026},
doi = {10.1371/journal.pone.0358555}
}
EUVIMED